Postoperative critical care of the adult cardiac surgical patient: Part II: Procedure-specific considerations, management of complications, and quality improvement
RS Stephens, GJR Whitman - Critical care medicine, 2015 - journals.lww.com
Objectives: The armamentarium of cardiac surgery continues to expand, and the cardiac
intensivist must be familiar with a broad spectrum of procedures and their specific …
intensivist must be familiar with a broad spectrum of procedures and their specific …
Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients
NA Guzzetta, IA Russell, GD Williams - Anesthesia & Analgesia, 2012 - journals.lww.com
In recent years the off-label use of recombinant activated factor VII (rFVIIa) has markedly
increased, particularly in pediatric cardiac surgery patients, and practitioners differ widely in …
increased, particularly in pediatric cardiac surgery patients, and practitioners differ widely in …
Intraoperative use of low-dose recombinant activated factor VII during thoracic aortic operations
ND Andersen, SD Bhattacharya, JB Williams… - The Annals of thoracic …, 2012 - Elsevier
BACKGROUND: Numerous studies have supported the effectiveness of recombinant
activated factor VII (rFVIIa) for the control of bleeding after cardiac procedures; however …
activated factor VII (rFVIIa) for the control of bleeding after cardiac procedures; however …
Trends in resource utilization associated with the inpatient treatment of neonatal congenital heart disease
AH Smith, JC Gay, NR Patel - Congenital heart disease, 2014 - Wiley Online Library
Introduction While neonates account for a significant proportion of health care expenditures
related to inpatient care for congenital heart disease, key drivers of resource utilization …
related to inpatient care for congenital heart disease, key drivers of resource utilization …
[HTML][HTML] The effect of intravenous administration of active recombinant factor VII on postoperative bleeding in cardiac valve reoperations; a randomized clinical trial
N Payani, M Foroughi, A Dabbagh - Anesthesiology and Pain …, 2015 - ncbi.nlm.nih.gov
Background: Postoperative bleeding after cardiac reoperations is among the most
complicating problems, both for the physicians and for the patients. Many modalities have …
complicating problems, both for the physicians and for the patients. Many modalities have …
Antithrombotic and hemostatic stewardship: evaluation of clinical outcomes and adverse events of recombinant factor VIIa (Novoseven®) utilization at a large …
K Marsh, D Green, V Raco… - Therapeutic …, 2020 - journals.sagepub.com
Background: Recombinant factor VIIa (rFVIIa)(Novoseven®) is utilized for the reversal of
anticoagulation-associated bleeding and refractory bleeding in cardiac surgery. In August …
anticoagulation-associated bleeding and refractory bleeding in cardiac surgery. In August …
[HTML][HTML] Recombinant activated factor VII for uncontrolled bleeding postcardiac surgery
AM Habib, AY Mousa, Z Al-Halees - Journal of the Saudi Heart Association, 2016 - Elsevier
A retrospective observational study to review the safety and efficacy of rFVIIa in persistent
hemorrhage in post cardiac surgical patients. Methods Patients who had bleeding of 3 …
hemorrhage in post cardiac surgical patients. Methods Patients who had bleeding of 3 …
A propensity-score matched analysis on outcomes using recombinant activated factor VII in pediatric cardiac surgery
Y Li, W Zhao, Q Luo, X Wu, J Ding, F Yan - Journal of Cardiothoracic and …, 2019 - Elsevier
Objective To evaluate the effect of recombinant activated factor VII (rFVIIa) administration on
outcomes in pediatric cardiac surgery patients with postoperative bleeding. Design A …
outcomes in pediatric cardiac surgery patients with postoperative bleeding. Design A …
Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac …
JP Scott, DJ Costigan, GM Hoffman… - Journal of clinical …, 2014 - Elsevier
Abstract Study Objective To evaluate whether conversion from aprotinin to epsilon-
aminocaproic acid (EACA) during infant cardiac surgery was associated with increased …
aminocaproic acid (EACA) during infant cardiac surgery was associated with increased …
Evaluation of anticoagulation and nonsurgical major bleeding in recipients of continuous‐flow left ventricular assist devices
TM Veasey, CK Floroff, SE Strout, KL McElray… - Artificial …, 2019 - Wiley Online Library
Continuous‐flow left ventricular assist device (LVAD) placement has become a standard of
care in advanced heart failure treatment. Bleeding is the most frequently reported adverse …
care in advanced heart failure treatment. Bleeding is the most frequently reported adverse …